The electoral commissioner announced suspected postal-vote tampering in elections at Knox and Whittlesea councils, where ...

Phase 2 trial evaluating eseba-vec/pembrolizumab combination resulted in a 52% ORR in PD-L1 CPS>20 patients and encouraging ...

Two councillors whose election wins are under a cloud of alleged voter fraud have denied wrongdoing and called for a quick ...

Find out who the candidates are and the key issues in your local area in our in-depth coverage of Victorian council elections.See all 53 stories. Completed postal ballots received by the VEC include ...

Marelli launches its new AI-based Electronic Control Unit for engine and vehicle control in motorsport applications, designed ...

Thermo Fisher is closing a factory in Lexington, MA, and merging operations with a newer facility in Plainville, MA, to ...

HOOKIPA Pharma (HOOK) announced that researchers at Memorial Sloan Kettering Cancer Center, MSKCC, have dosed the first patients in an ...

LUNA and 4-year OPTIC data, alongside Phase 3 trial design updates, anticipated in Q4 2024- Appointed Jason Mitchell as chief ...

Alleged voting irregularities in Whittlesea’s Lalor Ward have been referred to police and the Local Government Inspectorate ...

Genelux focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from solid tumor types.

HOOKIPA Pharma Inc. (NASDAQ: HOOK) (”HOOKIPA” or the “Company”), a clinical-stage biopharmaceutical company developing next generation immunotherapeutics for the treatment ...

周二，H.C. Wainwright维持了对Adverum Biotechnologies (NASDAQ:ADVM)的买入评级和30.00美元的目标价，对公司即将发布的临床更新表示乐观。该公司预计2024年第四季度将有三个重要更新，包括Phase 2 LUNA试验的52周更新、Phase 1 OPTIC试验的4年临床数据，以及预计于2025年上半年开始的Phase 3试验的额外设计细节。